13F-HR filed by Opaleye Management Inc.
Opaleye Management Inc. filed this 13F-HR for the quarter ended 2016-09-30, filed 2016-11-14, with 44 holding rows worth $191,082,000.
- Accession
- 0001546927-16-000542
- Filer
- CIK 1595855
- Filed
- 2016-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2016
A holdings report, 44 entries on the cover page, a total value of $191,082,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $191,082,000 with VALUE read as thousands by filing date, 13F file number 028-15896. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 785,000 | $23,315,000 | thousands by filing date | |
| AXOGEN INC | 05463X106 | COM | 2,000,000 | $18,060,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 1,045,000 | $14,306,000 | thousands by filing date | |
| Medgenics Inc New | 58436Q203 | COM NEW | 1,800,000 | $10,026,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 130,000 | $6,867,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 330,000 | $6,831,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 630,000 | $5,834,000 | thousands by filing date | |
| CARA THERAPEUTICS INC | 140755109 | COM | 675,000 | $5,636,000 | thousands by filing date | |
| CODEXIS INC | 192005106 | COM | 1,170,000 | $5,195,000 | thousands by filing date | |
| CYNAPSUS THERAPEUTICS INC | 23257Y859 | COM PAR NO PAR | 125,000 | $5,029,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 275,000 | $4,986,000 | thousands by filing date | |
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 70,000 | $4,900,000 | thousands by filing date | |
| IMPRIMIS PHARMA IMMY | 45323A201 | COMMON | 1,215,381 | $4,631,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 200,000 | $4,610,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365AAB7 | NOTE 4.500% 9/1 | 8,070,000 | $4,600,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 145,000 | $4,337,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 780,000 | $4,321,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 310,000 | $4,142,000 | thousands by filing date | |
| ADAMAS PHARMACEUTICALS INC | 00548A106 | COM | 250,000 | $4,103,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 1,200,000 | $3,900,000 | thousands by filing date | |
| ITEK 5 02/15/20 | 45780VAA0 | Bond 30/360P2 U | 400,000 | $3,792,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 410,000 | $3,321,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 50,000 | $2,999,000 | thousands by filing date | |
| EDGE THERAPEUTICS INC | 279870109 | COM | 280,000 | $2,915,000 | thousands by filing date | |
| LOXO ONCOLOGY INC | 548862101 | COM | 110,000 | $2,880,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 175,000 | $2,587,000 | thousands by filing date | |
| ZOGENIX INC | 98978L105 | COM | 220,000 | $2,515,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 160,000 | $2,509,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 35,000 | $2,483,000 | thousands by filing date | |
| PROTEOSTASIS THERAPEUTICS IN | 74373B109 | COM | 152,000 | $2,370,000 | thousands by filing date | |
| Lion Biotechnologies | 53619R102 | COM | 280,000 | $2,304,000 | thousands by filing date | |
| CORIUM INTL INC | 21887L107 | COM | 400,000 | $2,252,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 700,000 | $2,233,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 98,500 | $1,821,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS AG | 62957M104 | SPONSORED ADR | 239,500 | $1,688,000 | thousands by filing date | |
| INNOCOLL HLDGS PLC | G4783X105 | SHS | 269,100 | $1,563,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 430,000 | $1,195,000 | thousands by filing date | |
| INTEC PHARMA LTD JERUSALEM | M53644106 | SHS | 175,000 | $1,029,000 | thousands by filing date | |
| TENAX THERAPEUTICS INC | 88032L100 | COM | 390,000 | $905,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC | 737010908 | COM | 35,000 | $795,000 | thousands by filing date | |
| ABEONA THERAPEUTICS INC | 00289Y107 | COM | 100,000 | $600,000 | thousands by filing date | |
| AMAG PHARMACEUTICALS INC | 00163U106 | COM | 15,000 | $368,000 | thousands by filing date | |
| BIOLINERX LTD-SPONS ADR | 09071M106 | SPON | 250,000 | $288,000 | thousands by filing date | |
| DEPOMED INC | 249908104 | COM | 1,650 | $41,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001546927-16-000542 | this filing | 2016-11-14 | acceptance time not in the bulk data set |